Insider sale notices at Surgery Partners (NASDAQ: SGRY) show 5,798 and 10,082 shares

Rhea-AI Filing Summary

Surgery Partners, Inc. reports proposed sales of its common stock tied to recent equity vesting, including 5,798 shares noted with an 03/02/2026 vesting date. The filing also records a 3/6/2026 sale of 10,082 shares by Jennifer Baldock.

Insights

Compliance Officer

Notice of proposed resale and a recent disposition by an insider.

The filing lists a proposed sale of 5,798 common shares associated with equity vesting on 03/02/2026. It separately records a sale of 10,082 shares by Jennifer Baldock on 03/06/2026.

These items are procedural notifications under resale rules; timing and cash‑flow treatment are not disclosed in the excerpt. Subsequent SEC filings may report transaction settlement details or additional dispositions.

FAQ

What does Surgery Partners' Form 144 disclose about share sales?

The Form 144 notes a proposed sale of 5,798 shares tied to equity vesting on 03/02/2026 and a reported sale of 10,082 shares by Jennifer Baldock on 03/06/2026.

Who reported the recent sale in the Form 144 for SGRY?

The sale on 03/06/2026 was reported for Jennifer Baldock, who disposed of 10,082 common shares according to the filing excerpt.

Are the shares to be sold by Surgery Partners part of equity compensation?

Yes, the filing links the listed 5,798 common shares to equity vesting with the vesting date shown as 03/02/2026 in the excerpt.

Does the Form 144 indicate who receives proceeds from the sales?

The excerpt does not state proceeds treatment. It lists proposed and reported share quantities and vesting dates but does not specify who will receive or has received cash from these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/12/2026 - 01:42 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001650314
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Surgery Partners, Inc.
SEC File Number	001-37576
Address of Issuer	340 Seven Springs Way, Suite 600 Brentwood TENNESSEE 37027
Phone	(615) 234-5900
Name of Person for Whose Account the Securities are To Be Sold	Jennifer Baldock
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	5798	76384.71	129341779	03/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	03/02/2026	equity vesting	Surgery Partners, Inc.			5798	03/02/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jennifer Baldock 915 Dorset Drive Brentwood TN 37027	common	03/06/2026	10082	138123

144: Remarks and Signature

Remarks
Date of Notice	03/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Jennifer Baldock
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)